全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1889279-16-6 | A-485;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide | C25H24F4N4O5 |
| 1889970-48-2 | alpha-Amino-2,4-dichlorobenzenepropanenitrile | C9H8Cl2N2 |
| 1890228-73-5 | Boc-his(trt)-aib-glu(otbu)-gly-OH;2-[[(2S)-2-[[2-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(1-tritylimidazol-4-yl)propanoyl]amino]propanoyl]amino]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]acetic acid | C45H56N6O9 |
| 1892397-17-9 | 4,4-Difluoro-3,3-dimethylbutanoic acid | C6H10F2O2 |
| 1892578-21-0 | tert-Butyl 7-oxo-4-azaspiro[2.5]octane-4-carboxylate | C12H19NO3 |
| 1893125-36-4 | 6-Chloro-2-methyl-2H-indazol-5-amine | C8H8ClN3 |
| 1895296-01-1 | 3,3,3-Trifluoro-2,2-dimethylpropan-1-ol | C5H9F3O |
| 1895865-11-8 | Enzalutamide Impurity J;Unii-XY75X598XN;1,3-bis[4-cyano-3-(trifluoromethyl)phenyl]urea | C17H8F6N4O |
| 1898283-02-7 | 4-[[4-[[1-Cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-2-pyridinyl]amino]-alpha,alpha-dimethyl-2-pyridinemethanol | C24H29N5O3 |
| 1899834-30-0 | Methyl 3-tert-butyl-1,2,4-oxadiazole-5-carboxylate | C8H12N2O3 |
| 1902173-16-3 | Spiratisanin A;[(1R,2R,4R,9R,10S,12S,13R)-13-hydroxy-5,5,9,13-tetramethyl-2-tetracyclo[10.2.2.01,10.04,9]hexadecanyl] (E)-3-phenylprop-2-enoate | C29H40O3 |
| 1902954-87-3 | Abeprazan hydrochloride;1-[5-(2,4-difluorophenyl)-1-(3-fluorophenyl)sulfonyl-4-methoxypyrrol-3-yl]-N-methylmethanamine hydrochloride | C19H18ClF3N2O3S |
| 1903768-17-1 | (2S,4R)-1-[2-[3-Acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-4-fluoro-2-Pyrrolidinecarboxamide;ACH 0144471; ACH 4471; Danicopan | C26H23BrFN7O3 |
| 1908444-28-9 | Obeticholic Acid Dimer;7-epi-Obeticholic acid 3-obeticholate ester;(4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-[(4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]oxy-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | C52H86O7 |
| 1909293-52-2 | (3S,4S)-4-Fluoro-3-pyrrolidinol hydrochloride (1:1) | C4H8FNO.HCl |
| 1909295-00-6 | rac-(4aS,8aR)-Hexahydro-2H-pyrido[4,3-b][1,4]oxazin-3(4H)-one dihydrochloride | C7H14Cl2N2O2 |
| 1910124-24-1 | N-[2,3-Dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide | C22H27N5O3 |
| 1911644-32-0 | Ruxolitinib Amide;3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanamide | C17H20N6O |
| 1912400-29-3 | 3-[3-[(Trifluoromethyl)thio]phenyl]-1H-pyrazol-5-amine | C10H8F3N3S |
| 1916569-82-8 | (R)-2-Amino-2-(4-bromophenyl)ethanol hydrochloride;(2R)-2-amino-2-(4-bromophenyl)ethanol;hydrochloride | C8H11BrClNO |
| 1916571-90-8 | N-(4,6-Dimethyl-2-pyridinyl)-4-[[4-(trifluoromethyl)phenyl]methyl]-1-piperazinecarbothioamide;NCT 503 | C20H23F3N4S |
| 1917333-91-5 | Ibrutinib Impurity 26;3-(4-phenoxyphenyl)-5-[(3R)-1-prop-2-enoylpiperidin-3-yl]-4,5,7,9,13-pentazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7-tetraen-12-one | C28H26N6O3 |
| 1922121-95-6 | 2-(Dibenzo[b,d]furan-4-yl)-9H-carbazole | C24H15NO |
| 1923833-60-6 | cis-(alphaR)-N-(4-Chlorophenyl)-4-(6-fluoro-4-quinolinyl)-alpha-methylcyclohexaneacetamide | C24H24ClFN2O |
| 1923836-99-0 | 4-(6-Fluoro-4-quinolinyl)cyclohexanone | C15H14FNO |
| 1924596-31-5 | Mal-amido-PEG8-TFP ester;(2,3,5,6-tetrafluorophenyl) 3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate | C32H44F4N2O13 |
| 1926163-23-6 | Leuprolide Acetate EP Impurity E;N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid | C61H85F3N16O14 |
| 1926163-25-8 | Leuprolide Acetate EP Impurity D;[3-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-[[2-[[3-(1H-imidazol-5-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-oxopropyl] acetate;2,2,2-trifluoroacetic acid | C63H87F3N16O15 |
| 1926163-26-9 | Leuprolide EP Impurity I;(Des-Gly10,D-Pyr1,D-Leu6,Pro-NHEt9)-LHRH Trifluoroacetate;(2R)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid | C61H85F3N16O14 |
| 1927857-61-1 | 4-(Difluoromethyl)-5-[4-[(3S)-3-methyl-4-morpholinyl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-2-pyridinamine | C18H23F2N7O2 |
| 1928758-79-5 | 6-(Trifluoromethyl)-4(3H)-pteridinone | C7H3F3N4O |
| 1932056-72-8 | tert-butyl (3S,5S)-3-amino-5-fluoropiperidine-1-carboxylate | C10H19FN2O2 |
| 1932499-00-7 | (3r,4r)-Rel-3-amino-1-boc-4-fluoropiperidine | C10H19FN2O2 |
| 1936626-65-1 | 6-(Phenylmethyl)-2-thia-6-azaspiro[3.3]heptane | C12H15NS |
| 1940180-18-6 | 4-chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazine | C10H8ClN5 |
| 1942054-60-5 | Brivaracetam Impurity 26;(R)-3-(bromomethyl)hexanoic acid | C7H13BrO2 |
| 1942114-09-1 | alpha-(5-Fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-2H-isoindole-2-acetamide;EAI 045 | C19H14FN3O3S |
| 1943733-16-1 | N-[2-(5-Chloro-2-pyridinyl)ethyl]-4-[[[(4-methoxyphenyl)sulfonyl]amino]methyl]benzamide;YU 238259 | C22H22ClN3O4S |
| 1945965-95-6 | Ropivacaine EP Impurity F;(8as)-2-(2,6-dimethylphenyl)-3,3-dimethylhexahydroimidazo(1,5-a)pyridin-1(5H)-one | C17H24N2O |
| 1946806-94-5 | N-([1,1'-Biphenyl]-4-yl)-3'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-amine;N-[4-(3-carbazol-9-ylphenyl)phenyl]-4-phenylaniline | C36H26N2 |
| 1948273-00-4 | (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamine | C12H14N2S |
| 1948273-01-5 | (alphaS)-alpha-Methyl-4-(4-methyl-5-thiazolyl)benzenemethanamine hydrochloride (1:1);(S)-1-(4-(4-Methylthiazol-5-yl)phenyl)ethanamine hydrochloride | C12H14N2S.HCl |
| 1948273-02-6 | E3 ligase Ligand 1A;(2S,4R)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide | C23H32N4O3S |
| 1948273-03-7 | (4R)-3-Methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-L-prolinamide hydrochloride (1:1);E3 ligase Ligand 1 | C23H32N4O3S.HCl |
| 1951441-43-2 | trans-3-Fluorocyclohexanamine HCl;(1R,3R)-3-fluorocyclohexan-1-amine;hydrochloride | C6H13ClFN |
| 1951483-29-6 | 5,6-Dihydro-6,6-dimethyl-2-[2-[(1-methyl-1H-pyrazol-5-yl)amino]-4-pyrimidinyl]-5-[2-(4-morpholinyl)ethyl]-4H-thieno[2,3-c]pyrrol-4-one | C22H27N7O2S |
| 1952236-05-3 | N-[2-Chloro-5-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-3-pyridinyl]methanesulfonamide | C20H14Cl2FN5O2S |
| 1952316-43-6 | 4-[8-Amino-3-[(2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide | C26H23N7O2 |
| 1952360-91-6 | Fmoc-N-amido-PEG12-propionic acid;3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid | C42H65NO16 |
| 1953133-47-5 | (1R,3R)-1-[2,6-Difluoro-4-[[1-(3-fluoropropyl)-3-azetidinyl]amino]phenyl]-β,β-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido[3,4-b]indole-2-propanol;GDC 9545; Giredestrant; RG 6171; RG-6171; RG6171 | C27H31F5N4O |